Hannelouise Kissow

Hannelouise Kissow

Associate Professor

  1. Published

    Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis. / Billeschou, Anna; Hunt, Jenna; Kissow, Hannelouise.

    In: Journal of visualized experiments : JoVE, No. 147, e59236, 12.05.2019.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Glucagon-like peptide-1 is a marker of systemic inflammation in patients treated with high-dose chemotherapy and autologous stem cell transplantation. / Ebbesen, M S; Kissow, H; Hartmann, B; Grell, K; Gørløv, J S; Kielsen, K; Holst, J J; Müller, K.

    In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 6, 2019, p. 1085-1091.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome : a randomised phase 2 trial. / Naimi, Rahim M; Hvistendahl, Mark; Enevoldsen, Lotte H; Madsen, Jan L; Fuglsang, Stefan; Poulsen, Steen Seier; Kissow, Hannelouise; Pedersen, Jens; Nerup, Nikolaj; Ambrus, Rikard; Achiam, Michael P; Svendsen, Lars B; Holst, Jens Juul; Hartmann, Bolette; Hansen, Svend H; Dragsted, Lars Ove; Steensberg, Adam; Mouritzen, Ulrik; Hansen, Mark B; Jeppesen, Palle Bekker.

    In: The Lancet Gastroenterology and Hepatology, Vol. 4, No. 5, 2019, p. 354-363.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Animal models of mucositis : critical tools for advancing pathobiological understanding and identifying therapeutic targets. / Wardill, Hannah R; Tissing, Wim J E; Kissow, Hannelouise; Stringer, Andrea M.

    In: Current Opinion in Supportive and Palliative Care, Vol. 13, No. 2, 2019, p. 119-133 .

    Research output: Contribution to journalReviewResearchpeer-review

ID: 925016